In VivoDevice Transactions Device financing during 2015's third quarter reached $1.4 billion, a 22% dip from Q2's $1.8 billion total. ( See Exhibit 1. ) Late-stage venture capital rounds represented most of
ScripIN VITRO DIAGNOSTICS Interleukin Genetics Inc. New York University New York University School of Medicine Interleukin Genetics, NYU School of Medicine to develop genetic test for OA Interleukin Ge